Dr. Yuliya Knyahnytska, MD/PhD. Clinical Director of Interventional Psychiatry Department and Staff Psychiatrist with the Providence Care Hospital, Assistant Professor Faculty of Medicine, Queen’s University. Collaborator Scientist with the Centre for Addiction and Mental Health (CAMH, Toronto, ON) where she continues to serve as PI on clinical trials to explore the impact of ketamine on suicidality and severe depression. Dr. Knyahnytska has developed her expertise is treatment-resistant mood disorders through comprehensive training by completing two clinical fellowships (CAMH, Toronto), PhD with the University of Toronto, and her and her extensive involvement in multiple clinical trials with focus on innovative novel interventions. Her current research interests include interventional psychiatry, specifically brain stimulation interventions (ECT, MST, TMS, tDCS, PBM, etc), and ketamine; as well as focus at implementation science by enhancing access to care via clinical trials to improve quality of life for marginalized and hard-to-treat populations.